Loading…
Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies
Three monoclonal antibodies, raised against human milk fat globule membranes, have been applied to 194 primary human breast carcinomas. The detected antigenic sites were found to be heterogeneously distributed. A statistical association with estrogen receptor content and grade of anaplasia was found...
Saved in:
Published in: | Cancer research (Chicago, Ill.) Ill.), 1985-03, Vol.45 (3), p.1424-1427 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 1427 |
container_issue | 3 |
container_start_page | 1424 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 45 |
creator | Rasmussen, B B Pedersen, B V Thorpe, S M Hilkens, J Hilgers, J Rose, C |
description | Three monoclonal antibodies, raised against human milk fat globule membranes, have been applied to 194 primary human breast carcinomas. The detected antigenic sites were found to be heterogeneously distributed. A statistical association with estrogen receptor content and grade of anaplasia was found for two of the antigens, Mam 3a and Mam 3b. The presence of all three antigens was independent of menopausal status, age, primary lymph node metastases, and progesterone receptor status. Life table analysis showed a better survival for patients with tumors positive for Mam 3b. The effect of these variables on recurrence-free survival has been analyzed using a Cox regression model. It is found that the most important prognostic factors are the number of positive lymph nodes, the estrogen receptor content, and the menopausal status of the high-risk patients. The ability of a model based on these factors to predict recurrence is not significantly improved by including any of the three surface antigens. |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_75982613</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75982613</sourcerecordid><originalsourceid>FETCH-LOGICAL-h270t-a7ad11c4df78c8595683bb42aaf3077a0cadb7b66e779a87bd72e89777c05c6b3</originalsourceid><addsrcrecordid>eNqFkL1OwzAURjOASik8ApInJiI5cZzrjKjip1IlGGCOru2bNlViF9tB6ttTQXamT590dIZzkS055yqXFZRX2XWMh_OVBZeLbCEaKISSy-zwHvzO-Zh6w75xmIj5jsUpdGiIoUv9jlxkvWPH0I8YTmw_jeiYDoQxMYPB9M6PGB-YpUQmkWX6xEbvvBm8w-HXob3tKd5klx0OkW7nXWWfz08f69d8-_ayWT9u830JPOUIaIvCVLYDZZRsZK2E1lWJ2AkOgNyg1aDrmgAaVKAtlKQaADBcmlqLVXb_5z0G_zVRTO3YR0PDgI78FFuQjSrrQvwLFlXBq1LwM3g3g5MeybZzi3auKH4AyThvGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14104230</pqid></control><display><type>article</type><title>Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>Rasmussen, B B ; Pedersen, B V ; Thorpe, S M ; Hilkens, J ; Hilgers, J ; Rose, C</creator><creatorcontrib>Rasmussen, B B ; Pedersen, B V ; Thorpe, S M ; Hilkens, J ; Hilgers, J ; Rose, C</creatorcontrib><description>Three monoclonal antibodies, raised against human milk fat globule membranes, have been applied to 194 primary human breast carcinomas. The detected antigenic sites were found to be heterogeneously distributed. A statistical association with estrogen receptor content and grade of anaplasia was found for two of the antigens, Mam 3a and Mam 3b. The presence of all three antigens was independent of menopausal status, age, primary lymph node metastases, and progesterone receptor status. Life table analysis showed a better survival for patients with tumors positive for Mam 3b. The effect of these variables on recurrence-free survival has been analyzed using a Cox regression model. It is found that the most important prognostic factors are the number of positive lymph nodes, the estrogen receptor content, and the menopausal status of the high-risk patients. The ability of a model based on these factors to predict recurrence is not significantly improved by including any of the three surface antigens.</description><identifier>ISSN: 0008-5472</identifier><identifier>PMID: 3971385</identifier><language>eng</language><publisher>United States</publisher><subject>Antibodies, Monoclonal - immunology ; antigens ; Antigens, Neoplasm - analysis ; Antigens, Surface - analysis ; Breast Neoplasms - immunology ; Breast Neoplasms - mortality ; carcinoma ; cell surface ; Female ; Humans ; Lymphatic Metastasis ; mammary gland ; man ; monoclonal antibodies ; Prognosis ; Receptors, Estrogen - analysis ; Regression Analysis</subject><ispartof>Cancer research (Chicago, Ill.), 1985-03, Vol.45 (3), p.1424-1427</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3971385$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rasmussen, B B</creatorcontrib><creatorcontrib>Pedersen, B V</creatorcontrib><creatorcontrib>Thorpe, S M</creatorcontrib><creatorcontrib>Hilkens, J</creatorcontrib><creatorcontrib>Hilgers, J</creatorcontrib><creatorcontrib>Rose, C</creatorcontrib><title>Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Three monoclonal antibodies, raised against human milk fat globule membranes, have been applied to 194 primary human breast carcinomas. The detected antigenic sites were found to be heterogeneously distributed. A statistical association with estrogen receptor content and grade of anaplasia was found for two of the antigens, Mam 3a and Mam 3b. The presence of all three antigens was independent of menopausal status, age, primary lymph node metastases, and progesterone receptor status. Life table analysis showed a better survival for patients with tumors positive for Mam 3b. The effect of these variables on recurrence-free survival has been analyzed using a Cox regression model. It is found that the most important prognostic factors are the number of positive lymph nodes, the estrogen receptor content, and the menopausal status of the high-risk patients. The ability of a model based on these factors to predict recurrence is not significantly improved by including any of the three surface antigens.</description><subject>Antibodies, Monoclonal - immunology</subject><subject>antigens</subject><subject>Antigens, Neoplasm - analysis</subject><subject>Antigens, Surface - analysis</subject><subject>Breast Neoplasms - immunology</subject><subject>Breast Neoplasms - mortality</subject><subject>carcinoma</subject><subject>cell surface</subject><subject>Female</subject><subject>Humans</subject><subject>Lymphatic Metastasis</subject><subject>mammary gland</subject><subject>man</subject><subject>monoclonal antibodies</subject><subject>Prognosis</subject><subject>Receptors, Estrogen - analysis</subject><subject>Regression Analysis</subject><issn>0008-5472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><recordid>eNqFkL1OwzAURjOASik8ApInJiI5cZzrjKjip1IlGGCOru2bNlViF9tB6ttTQXamT590dIZzkS055yqXFZRX2XWMh_OVBZeLbCEaKISSy-zwHvzO-Zh6w75xmIj5jsUpdGiIoUv9jlxkvWPH0I8YTmw_jeiYDoQxMYPB9M6PGB-YpUQmkWX6xEbvvBm8w-HXob3tKd5klx0OkW7nXWWfz08f69d8-_ayWT9u830JPOUIaIvCVLYDZZRsZK2E1lWJ2AkOgNyg1aDrmgAaVKAtlKQaADBcmlqLVXb_5z0G_zVRTO3YR0PDgI78FFuQjSrrQvwLFlXBq1LwM3g3g5MeybZzi3auKH4AyThvGQ</recordid><startdate>19850301</startdate><enddate>19850301</enddate><creator>Rasmussen, B B</creator><creator>Pedersen, B V</creator><creator>Thorpe, S M</creator><creator>Hilkens, J</creator><creator>Hilgers, J</creator><creator>Rose, C</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19850301</creationdate><title>Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies</title><author>Rasmussen, B B ; Pedersen, B V ; Thorpe, S M ; Hilkens, J ; Hilgers, J ; Rose, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h270t-a7ad11c4df78c8595683bb42aaf3077a0cadb7b66e779a87bd72e89777c05c6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Antibodies, Monoclonal - immunology</topic><topic>antigens</topic><topic>Antigens, Neoplasm - analysis</topic><topic>Antigens, Surface - analysis</topic><topic>Breast Neoplasms - immunology</topic><topic>Breast Neoplasms - mortality</topic><topic>carcinoma</topic><topic>cell surface</topic><topic>Female</topic><topic>Humans</topic><topic>Lymphatic Metastasis</topic><topic>mammary gland</topic><topic>man</topic><topic>monoclonal antibodies</topic><topic>Prognosis</topic><topic>Receptors, Estrogen - analysis</topic><topic>Regression Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rasmussen, B B</creatorcontrib><creatorcontrib>Pedersen, B V</creatorcontrib><creatorcontrib>Thorpe, S M</creatorcontrib><creatorcontrib>Hilkens, J</creatorcontrib><creatorcontrib>Hilgers, J</creatorcontrib><creatorcontrib>Rose, C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rasmussen, B B</au><au>Pedersen, B V</au><au>Thorpe, S M</au><au>Hilkens, J</au><au>Hilgers, J</au><au>Rose, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1985-03-01</date><risdate>1985</risdate><volume>45</volume><issue>3</issue><spage>1424</spage><epage>1427</epage><pages>1424-1427</pages><issn>0008-5472</issn><abstract>Three monoclonal antibodies, raised against human milk fat globule membranes, have been applied to 194 primary human breast carcinomas. The detected antigenic sites were found to be heterogeneously distributed. A statistical association with estrogen receptor content and grade of anaplasia was found for two of the antigens, Mam 3a and Mam 3b. The presence of all three antigens was independent of menopausal status, age, primary lymph node metastases, and progesterone receptor status. Life table analysis showed a better survival for patients with tumors positive for Mam 3b. The effect of these variables on recurrence-free survival has been analyzed using a Cox regression model. It is found that the most important prognostic factors are the number of positive lymph nodes, the estrogen receptor content, and the menopausal status of the high-risk patients. The ability of a model based on these factors to predict recurrence is not significantly improved by including any of the three surface antigens.</abstract><cop>United States</cop><pmid>3971385</pmid><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 1985-03, Vol.45 (3), p.1424-1427 |
issn | 0008-5472 |
language | eng |
recordid | cdi_proquest_miscellaneous_75982613 |
source | Free E-Journal (出版社公開部分のみ) |
subjects | Antibodies, Monoclonal - immunology antigens Antigens, Neoplasm - analysis Antigens, Surface - analysis Breast Neoplasms - immunology Breast Neoplasms - mortality carcinoma cell surface Female Humans Lymphatic Metastasis mammary gland man monoclonal antibodies Prognosis Receptors, Estrogen - analysis Regression Analysis |
title | Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T00%3A31%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20value%20of%20surface%20antigens%20in%20primary%20human%20breast%20carcinomas,%20detected%20by%20monoclonal%20antibodies&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=Rasmussen,%20B%20B&rft.date=1985-03-01&rft.volume=45&rft.issue=3&rft.spage=1424&rft.epage=1427&rft.pages=1424-1427&rft.issn=0008-5472&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E75982613%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h270t-a7ad11c4df78c8595683bb42aaf3077a0cadb7b66e779a87bd72e89777c05c6b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=14104230&rft_id=info:pmid/3971385&rfr_iscdi=true |